Sudden cardiac death (SCD) from arrest is a major international public health problem accounting for an estimated 15%-20% of all deaths. Implantable cardioverter defibrillators (ICD) have been demonstrated to improve survival in high-risk populations. While 500,000 patients experience SCD annually, there are only 75,000 ICDs implanted annually suggesting significant treatment gap. To determine ...